Strategic consensus on heart failure in Portugal launched

News & Events

6 October 2020
AUTHOR: HFPN Admin

The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal (Universidade Católica Portuguesa, UCP) to develop a strategic consensus on heart failure in Portugal, which was launched today during a three-day virtual conference. The document highlights existing gaps and presents specific measures to address the challenge.

The UCP put together a working group to develop the consensus. This included cardiologists, internists, general practitioners, nurses, pharmacists, public health specialists, patient representatives, policymakers and industry representatives. The group met three times during 2019: first to discuss the current situation in Portugal regarding heart failure; secondly to focus on care models and potential measures to address the challenge; and finally to define the level of consensus on the measures proposed.

During 2020, the consensus document was revised in light of the COVID-19 pandemic, to reflect the sense of urgency to address heart failure and acknowledge some changes to elements of healthcare delivery driven by the pandemic.

HFPN Head of Programme Sara C Marques led the scientific coordination and write-up of the work. The report is available in Portuguese and English.

To find out more and read the consensus report, visit http://coracaodeportugal.dn.pt/o-consenso-estrategico-para-a-ic/

Tagged:

More from News & Events

9 things we learnt from the Heart Failure Policy Summit 2022
9 things we learnt from the Heart Failure Policy Summit 2022...
13 January 2023
Last year's Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points....
Read article
Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .